US FDA approves updated COVID vaccines for 2026-27 season

FDA approves new COVID-19 vaccine for seniors

The Food and Drug Administration on Thursday approved COVID-19 vaccines for the 2026-27 season for people at higher risk of severe illness, including everyone 65 and older and younger people with certain underlying health conditions. The FDA approved Moderna’s vaccine for people ages 6 months and older, Pfizer’s for those ages 5 and older, and Sanofi’s for people ages 12 and older. The agency also approved a lower-dose Moderna vaccine, mNEXSPIKE…

FDA Clears Updated Pfizer, Moderna and Sanofi COVID-19 Vaccines for Older and High-Risk Americans

The FDA has approved updated COVID-19 vaccines from Pfizer, Moderna and Sanofi targeting the XFG strain, with eligibility centered on adults 65 and older and ... The post FDA Clears Updated Pfizer, Moderna and Sanofi COVID-19 Vaccines for Older and High-Risk Americans first appeared on [your]NEWS.

FDA Approves 3 New COVID-19 Vaccines

The Food and Drug Administration on Aug. 27 approved COVID-19 vaccines from Pfizer, Moderna, and Sanofi. The new shots from Pfizer and Moderna use the messenger ribonucleic acid (mRNA) platform and target the XFG strain, a subvariant of the JN.1 variant. Regulators also cleared a COVID-19 vaccine shot from Sanofi that targets the XFG strain and does not use mRNA technology. The approval is for people aged 65 and older, as well as people aged 12 …

FDA Approves Updated COVID Vaccines (With A Catch)

The New York Times reports: The Food and Drug Administration approved updated Covid vaccines on Thursday, clearing the way for manufacturers to ship doses to pharmacies and doctors’ offices. Moderna and Pfizer, which make the most commonly used Covid vaccines, are expected to begin shipping soon; Pfizer said it would do so “immediately,” and Moderna has done so within days of approval in past years. Sanofi, which distributes a non-mRNA option ca…

Fall COVID Vaccines Receive FDA Approval

New COVID shots got the green light on Thursday, but actually getting one might not be straightforward. The FDA authorized updated vaccines from Moderna, Pfizer, and Sanofi/Novavax for this fall, aimed at the XFG variant now dominant in North America, the New York Times reports. Eligibility mirrors last year's: everyone...